Featured content

Browse the latest clinical insights, patient materials, product updates and answers to frequently asked questions. Register to access the full range of exclusive resources and information.

Updates in the management of MRD- B-ALL

Learn about recent developments in the treatment of newly-diagnosed, MRD- B-ALL

Clinical Report Haematology

Why and when to test for MRD in
B-ALL

Discover the standards of care in MRD testing and how to access it in Australia.

Clinical Report Haematology

Pathophysiology of TED

Watch a short video on pathophysiology, inflammatory cascade & consequences of TED.

Video Rare Diseases

Discover our latest content

Accessing BLINCYTO® on the PBS

Read on for PBS criteria for your patients with B-cell precursor acute lymphoblastic leukaemia

Clinical Report Haematology

Updates in the management of MRD- B-ALL

Learn about recent developments in the treatment of newly-diagnosed, MRD- B-ALL

Clinical Report Haematology

CRS: Considerations for blinatumomab

Read on for information on recognising, grading and managing CRS in B-ALL.

Clinical Report Haematology

Why and when to test for MRD in B-ALL

Discover the standards of care in MRD testing and how to access it in Australia.

Clinical Report Haematology

Neurotoxicity: Patient Management Considerations when using blinatumomab

Read on for information on recognising, grading and managing ICANS in B-ALL.

Clinical Report Haematology

Optimising Osteoporosis Treatment

As part of our commitment to supporting your practice, Amgen is pleased to provide you with a detailed summary of the breakfast session with Prof Peter R Ebeling AO,

Clinical Report Bone Health

Spot the Signs and Symptoms of Thyroid Eye Disease (TED)

Spotting TED and treating early can benefit patients and may reduce the impact of the disease, helping avoid potentially permanent eye damage.

Clinical Report Thyroid Eye Disease

About small cell lung cancer

Learn about the unmet needs in small cell lung cancer

Clinical Report Solid Tumours

DLL3 as a potential target

Learn about delta-like ligand 3 as a potential target in small cell lung cancer

Clinical Report Solid Tumours

T cell engager technology

Learn how T-cell engagers can be designed to bind to specific targets on tumour cells in SCLC and other high-grade NECs.

Clinical Report Solid Tumours

Evenity mechanism of action

Watch a short video about how Evenity produces its pharmacological effect

Video Bone Health

Evenity prefilled syringe administration

This video shows how to safely and securely administer Evenity

Video Bone Health

Advances in newly diagnosed B-ALL

Watch on demand as Shaun Fleming discusses advances in the treatment of newly diagnosed B-ALL.

Video Haematology

Treatment with Blinatumomab: Patient video

This video explains how BLINCYTO® (blinatumomab) works in the body and what treatment with BLINCYTO® (blinatumomab) involves.

Video Haematology

Pathophysiology of TED

Watch a short video on pathophysiology, inflammatory cascade & consequences of TED.

Video Thyroid Eye Disease

H2 Leaving Page Headline

Ut eum dolor sanis et at voluptur sintin corro of- fi cimpere nonsequis uta elia nimpo Datenschutzhinweise riorem aquam.

GO BACK TO XX SITE EXTERNAL PAGE